CYTK
Price
$73.77
Change
+$0.15 (+0.20%)
Updated
Sep 11 closing price
Capitalization
10.25B
47 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$21.24
Change
-$1.05 (-4.71%)
Updated
Sep 11 closing price
Capitalization
2.41B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CYTK vs VRDN

CYTK vs VRDN Comparison Chart in %
View a ticker or compare two or three
VS
CYTK vs. VRDN commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and VRDN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($10.3B) has a higher market cap than VRDN($2.41B). CYTK YTD gains are higher at: 16.100 vs. VRDN (-31.748). VRDN has higher annual earnings (EBITDA): -370.89M vs. CYTK (-756.63M). CYTK has more cash in the bank: 1.17B vs. VRDN (982M). VRDN has less debt than CYTK: VRDN (243M) vs CYTK (1.27B). VRDN (71.1M) and CYTK (67.7M) have equivalent revenues.
CYTKVRDNCYTK / VRDN
Capitalization10.3B2.41B428%
EBITDA-756.63M-370.89M204%
Gain YTD16.100-31.748-51%
P/E RatioN/AN/A-
Revenue67.7M71.1M95%
Total Cash1.17B982M119%
Total Debt1.27B243M523%
FUNDAMENTALS RATINGS
CYTK vs VRDN: Fundamental Ratings
CYTK
VRDN
OUTLOOK RATING
1..100
1669
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
6776
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4447
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRDN's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for CYTK (100). This means that VRDN’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (67) in the Biotechnology industry is in the same range as VRDN (76). This means that CYTK’s stock grew similarly to VRDN’s over the last 12 months.

VRDN's SMR Rating (98) in the Biotechnology industry is in the same range as CYTK (100). This means that VRDN’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (44) in the Biotechnology industry is in the same range as VRDN (47). This means that CYTK’s stock grew similarly to VRDN’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for VRDN (100). This means that CYTK’s stock grew significantly faster than VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKVRDN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CYTK: $73.77 vs. VRDN: $21.24)
Brand notoriety: CYTK and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 102% vs. VRDN: 53%
Market capitalization -- CYTK: $10.25B vs. VRDN: $2.41B
CYTK [@Biotechnology] is valued at $10.25B. VRDN’s [@Biotechnology] market capitalization is $2.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green while VRDN’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYTK and VRDN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 5 bearish.
  • VRDN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CYTK and VRDN are a bad buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а +1.44% price change this week, while VRDN (@Biotechnology) price change was -7.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 29, 2026.

VRDN is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CYTK
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RIOX27.341.34
+5.15%
Tidal Trust II Defiance Daily Target 2X Long RIOT ETF
IHDG52.340.52
+1.00%
WisdomTree Intl Hdgd Qual Div Gr ETF
ESIM29.270.20
+0.69%
Eventide International ETF
FXZ83.740.09
+0.11%
First Trust Materials AlphaDEX® ETF
PCPI50.08-0.01
-0.03%
PIMCO Inflation Plus Active ETF

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with MLTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-4.71%
MLTX - VRDN
42%
Loosely correlated
-5.08%
CYTK - VRDN
40%
Loosely correlated
+0.20%
VCYT - VRDN
39%
Loosely correlated
-2.76%
VKTX - VRDN
37%
Loosely correlated
-0.47%
RNA - VRDN
37%
Loosely correlated
+0.10%
More